Podcast


Presenter: G. Michael Allan MD CCFP James McCormack BSc (Pharm) Pharm D

In episode 539, James and Mike focus in a PREMIUM way on the latest prostate cancer intervention trial. Patients with prostate cancer were randomized to active monitoring, surgery, or radiotherapy and followed for 15 years to see which was the best option. Have a listen and hear what was found. Show Notes 1) Fifteen-Year Outcomes…

This content is for *CFPC Member Rate, CFPC Member Rate, Non-CFPC Member Rate, and Resident members only.
Login Join Now



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

BS Medicine Episode 551: Statins in older adults – there is an answer!

In episode 551, James and Mike invite Danielle Perry back to the podcast to talk about the best available evidence for the use of statins in people 65 and over.…
Listen 0.5 credits available

BS Medicine Episode 550: PREMIUM – Lipids and bempedoic acid – to be right look at what is left

In episode 550, James and Mike talk in a PREMIUM way about a new cholesterol lowering agent. Bempedoic acid is nothing tremendously exciting but what was very interesting was a…
Listen 0.5 credits available

BS Medicine Episode 549: Triglyce-Ride That High?

In episode 549, James and Mike invite Blair MacDonald to the podcast for the first time and we talk about a topic that we haven’t really covered to-date. We discuss…
Listen 0.5 credits available

Presenter(s):

G. Michael Allan MD CCFP James McCormack BSc (Pharm) Pharm D

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • G. Michael Allan MD CCFP
  • James McCormack BSc (Pharm) Pharm D

Spearkers do not have any conflicts of interest to declare.